A phase I study of ixabepilone combined with dasatinib in patients with solid tumors.

e13514 Background: Dasatinib is a small molecule inhibitor of multiple oncogenic tyrosine kinase families, including SRC. Ixabepilone is a novel microtubule-stabilizing epothilone that has shown cl...